BIOE Stock Overview
Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bio Essence Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.26 |
| 52 Week High | US$1.25 |
| 52 Week Low | US$0.24 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -74.26% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -48.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOE | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 2.2% |
| 1Y | -74.3% | 9.8% | 22.8% |
Return vs Industry: BIOE underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: BIOE underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| BIOE volatility | |
|---|---|
| BIOE Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BIOE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BIOE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 12 | Yin Yan | www.bioessencecorp.com |
Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States and internationally. It targets healthcare practitioners with herbal products in the form of granules, capsules, pills, and tablets; offers special formulation, original equipment manufacturing, and private label services to practitioners and other companies; and produces and distributes health supplement products. The company sells its products through TCM practitioners, online websites, brick-and-mortar stores, and other channels.
Bio Essence Corporation Fundamentals Summary
| BIOE fundamental statistics | |
|---|---|
| Market cap | US$9.88m |
| Earnings (TTM) | -US$802.55k |
| Revenue (TTM) | US$551.51k |
17.9x
P/S Ratio-12.3x
P/E RatioIs BIOE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOE income statement (TTM) | |
|---|---|
| Revenue | US$551.51k |
| Cost of Revenue | US$274.06k |
| Gross Profit | US$277.45k |
| Other Expenses | US$1.08m |
| Earnings | -US$802.55k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.021 |
| Gross Margin | 50.31% |
| Net Profit Margin | -145.52% |
| Debt/Equity Ratio | -123.0% |
How did BIOE perform over the long term?
See historical performance and comparison